Preferred Label : Chromosome 17q11.2 deletion syndrome, 1.4-mb;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Neurofibromatosis 1 microdeletion syndrome; Nf1 microdeletion syndrome; Van asperen syndrome;
Description : Approximately 5 to 20% of all patients with neurofibromatosis type I (162200) carry
a heterozygous deletion of approximately 1.4 Mb involving the NF1 gene and contiguous
genes lying in its flanking regions (Riva et al., 2000; Jenne et al., 2001), which
is caused by nonallelic homologous recombination of NF1 repeats A and C (Dorschner
et al., 2000). The 'NF1 microdeletion syndrome' is often characterized by a more severe
phenotype than that observed in the majority of NF1 patients. In particular, patients
with NF1 microdeletion often show variable facial dysmorphism, mental retardation,
developmental delay, an excessive number of early-onset neurofibromas (Venturin et
al., 2004), and an increased risk for malignant peripheral nerve sheath tumors (De
Raedt et al., 2003).;
Inheritance : Autosomal dominant;
Molecular basis : A contiguous gene deletion syndrome involving deletion of 1.4Mb on chromosome 17q11.2;
Neoplasia : Optic glioma (19%); Malignant peripheral nerve sheath tumors (21%);
Prefixed ID : #613675;
Origin ID : 613675;
UMLS CUI : C5401456;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
HPO term(s)
ORDO concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)